Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: myturn who wrote (19783)	1/12/2000 8:27:00 AM
From: myturn	Read Replies (1) \| Respond to of 150070

JMAR, traded as high as $13 in after hours trading and I can find anything on it except this PR. I will be shorting this one this morning if it goes back over $10. Tuesday January 11, 3:54 pm Eastern Time Company Press Release JMAR Receives $1.8 Million in Orders for DNA Biochip Manufacturing Systems Advanced Biochips Expected to Play Key Role in Speeding Biomedical Research SAN DIEGO--(BUSINESS WIRE)--Jan. 11, 2000--JMAR Technologies Inc. (Nasdaq:JMAR - news), announced today that its JMAR Precision Systems (JPSI) division has received orders valued at approximately $1.8 million from a leading DNA biochip company for several micro-positioning lithography alignment systems. These systems will enable the fabrication of biomedical products targeted at improving the diagnosis, monitoring and treatment of many diseases. DNA biochips are also being used for managing genetic information that can contribute to the study of the human aging process. According to the Oct. 25, 1999 ``Business Week' magazine, surveys by brokerage houses and market-research firms indicate an immediate market for biochips of about $1 billion -- with the potential to expand to $40 billion in the next decade. This increase should generate substantial growth opportunities for equipment and systems makers in this market. ``We are extremely pleased with the growing demand from the biotechnology industry for our precision products,' commented John S. Martinez, Ph.D. JMAR's chairman and chief executive officer. ``The biotech industry, long overshadowed by Silicon Valley, is now beginning to incorporate key semiconductor manufacturing techniques to accelerate the pace of its product introductions. The adaptation to the biochip market of JMAR's precision positioning, alignment and lithography technologies is a natural spin-off from our current semiconductor equipment product lines. ``Biochips look like the semiconductor chips used in many familiar electronic products, including computers, but instead of containing tiny microcircuits, they are loaded with micro-bits of DNA material,' Martinez continued, ``For example, when biochips are placed in contact with a material to be evaluated, they allow scientists and bio-medical professionals to perform large numbers of biochemical experiments at a fraction of the cost and time now required for conventional testing. Many industry analysts agree that biochips will bring genomics, the study of all of the genes in a living organism, out of the research laboratories and into the daily practice of medicine within the next few years. They are expected to do for biology what microprocessors did for computers. We are delighted to be a part of this vital and vibrant industry.' Fred Schiele, president of JPSI said, ``JMAR is firmly committed to supporting the precision manufacturing needs of the biochip industry. We anticipate that JMAR's powerful, growing arsenal of advanced technologies will position us to secure additional orders that will further expand our role in this exciting, rapidly growing market.' JMAR Technologies Inc. is a semiconductor industry-focused company. In addition to the products produced by JPSI, JMAR Technologies provides specialty semiconductor products for the microelectronics industry and is a leading developer of proprietary advanced light sources for lithography and other high value manufacturing and metrology applications. Please visit JMAR's Web site at www.jmar.com for additional information on the company. The statements regarding JMAR's expectations of the successful introduction of new products and future sales and potential business opportunities are forward-looking statements based on current expectations that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. These risks include the failure of future orders to materialize as expected, delays in shipment or cancellation of orders, failure of acceptance of new products, failure of advanced technology to perform as predicted and the other risks detailed in the company's Form 10-K and other reports filed with the SEC. Contact: JMAR Technologies Inc. Dennis E. Valentine, 858/535-1706 jmar.com